Mindblown: a blog about philosophy.

There is one place in southern China that accounts for one in every three smartphones, one in every two color TVs, and one in every three air conditioners sold worldwide. In 2025, the region’s total import and export volume reached 9.49 trillion yuan, ranking first in the nation for 40 consecutive years. This is Guangdong,…

New York, USA – GripVolt, a global automotive accessories brand focused on practical products for everyday driving, today shared the product development story behind its Car Thermal Cup Holder, following its growing adoption across North America, Europe, and Japan since its launch in early 2025. The product is designed to help drivers maintain beverage temperature…

Tampa, FL, USA – July 3, 2026 – Dr. Danielle M. Carrera, DNP, AAPRN-BC — nationally recognized expert in metabolic health, GLP-1 therapeutics, peptide medicine, and regenerative wellness; Founder & Clinical Director of Carrera Telehealth & Wellness; Co-Founder & CEO of Above Genetics; and Founder of the Bridge2Better Foundation — announces the worldwide release of…

Emerging Onychomycosis therapies including BB2603 (Blueberry Therapeutics), VT-1161 (Mycovia Pharmaceuticals), KERYDIN (tavaborole), JUBLIA/CLENAFIN (efinaconazole), and others are driving market size. DelveInsight’s “Onychomycosis Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of Onychomycosis, historical and forecasted epidemiology, as well as the Onychomycosis market trends in the United States, EU4 (Germany, France,…

DelveInsight’s “Non-Alcoholic Fatty Liver Disease Pipeline Insight 2026” report provides comprehensive insights about 90+ companies and 100+ pipeline drugs in the Non-Alcoholic Fatty Liver Disease pipeline landscape. It covers the Non Alcoholic Fatty Liver Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route…

DelveInsight’s “Marginal Zone Lymphoma Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Marginal Zone Lymphoma pipeline landscape. It covers the Marginal Zone Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Marginal Zone Lymphoma therapeutics assessment by product type, stage, route of…

DelveInsight’s “Neuroblastoma Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in the Neuroblastoma pipeline landscape. It covers the Neuroblastoma Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Neuroblastoma Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights…

DelveInsight’s, “Sjogren’s Syndrome Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Sjogren’s Syndrome pipeline landscape. It covers the Sjogren’s Syndrome pipeline drugs profiles, including clinical and nonclinical stage products. It also covers the Sjogren’s Syndrome pipeline therapeutics assessment by product type, stage, route of administration, and molecule type.…

DelveInsight’s, “HER2 Positive Breast Cancer Pipeline Insight, 2026” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in HER2 Positive Breast Cancer pipeline landscape. It covers the HER2 Positive Breast Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the HER2 Positive Breast Cancer pipeline therapeutics assessment by product…

The Chronic Refractory Gout (CRG) Market is growing due to the rising prevalence of chronic gout, uncontrolled hyperuricemia, and increasing demand for effective urate-lowering therapies. Growing awareness of treatment-resistant gout and the development of pipeline candidates such as NASP (SEL-212), ABP-671, and AR882 are expected to further drive market growth during the forecast period. DelveInsight,…